Etanercept Treatment for Children and Adolescents with Plaque Psoriasis

2008388 citationsJournal Articlebronze Open Access

Authors

Amy S. Paller · Lurie Children's Hospital

Elaine C. Siegfried · Cardinal Glennon Children’s Medical Center

Richard G. Langley · Dalhousie University

Alice B. Gottlieb · Tufts Medical Center

David M. Pariser · Virginia Clinical Research

Ian Landells · Nexus Clinical Research (Canada)

Adelaide A. Hebert

Abstract

Etanercept significantly reduced disease severity in children and adolescents with moderate-to-severe plaque psoriasis. (ClinicalTrials.gov number, NCT00078819 [ClinicalTrials.gov].).

Topics & Keywords

Psoriasis: Treatment and Pathogenesis Autoimmune and Inflammatory Disorders Research Asthma and respiratory diseases

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: New England Journal of Medicine

Volume 358, Issue 3, pp. 241-251

DOI: 10.1056/nejmoa066886

Field-Weighted Citation Impact: 12.77